Research Article
The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B
Table 3
Clinical characteristics of the CHB liver fibrosis and liver cirrhosis group cases (
).
| | Clinical data | Liver fibrosis group | Liver cirrhosis group | |
| | Male/female | 21/11 | 30/18 | 0.815 | | Age (years old) | | | 0.0001 | | Blood cell counts (109/L) | | | 0.025 | | Hemoglobin (g/L) | | | 0.001 | | Blood platelet (109/L) | | | 0.002 | | ALT (U/L) | | | 0.285 | | AST (U/L) | | | 0.023 | | γ-GT (U/L) | | | 0.926 | | ALP (U/L) | | | 0.985 | | T-Bil (μmol/L) | | | 0.160 | | D-Bil (μmol/L) | | | 0.177 | | TP (g/L) | | | 0.244 | | ALB (g/L) | | | 0.104 | | TC (U/L) | | | 0.004 | | TG (U/L) | | | 0.003 | | AFP | | | 0.029 | | INR | | | 0.001 | | HBV-DNA (107 U/L) | | | 0.932 | | HBeAg-positive rate (%) | 95% | 45% | 0.0001 |
|
|